Fintel reports that on January 30, 2025, William Blair downgraded their outlook for CARGO Therapeutics (NasdaqGS:CRGX) from ...
Equities researchers at William Blair issued their FY2025 EPS estimates for VSE in a research note issued on Monday, January 27th. William Blair analyst L. Dipalma anticipates that the construction ...
Stephanie Braming, global head of William Blair Investment Management, plans to retire in the fourth quarter, a news release ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 2.08% of ...
Investment analysts at William Blair increased their FY2024 earnings per share (EPS) estimates for VSE in a research note issued on Monday, January 27th. William Blair analyst L. Dipalma now expects ...
For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...
Neuronetics Inc (STIM) stock saw a modest uptick, ending the day at $3.01 which represents a slight increase of $0.47 or 18.50% from the prior close of $2.54. The stock opened at $2.67 and touched a ...
American Express beat expectations for fourth-quarter revenue on Friday, as more consumers swiped its cards during the ...
William Blair downgraded Charles River (CRL) to Market Perform from Outperform without a price target “There is simply too much working against Charles River in the near term to make the stock ...
American Express (NYSE:AXP)‘s stock had its “outperform” rating reaffirmed by analysts at William Blair in a research report issued on Monday,RTT News reports. William Blair also issued estimates for ...